STOCK TITAN
  1. Home
  2. Sec-filings
  3. STE
  4. [Form 4] STERIS plc Insider Trading Activity

STERIS plc (NYSE: STE) officer reports grant of 798 ordinary shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

STERIS plc filed a Form 4 reporting an equity award to a company officer. On January 2, 2026, a STERIS officer serving as VP, Chief Comp. & Quality Officer acquired 798 ordinary shares of STERIS plc at a reported price of $0 per share, indicating a share grant rather than an open-market purchase.

After this transaction, the officer beneficially owned 5,028 ordinary shares directly, of which 3,750 shares were restricted as of January 2, 2026. These restricted shares are scheduled to vest in tranches between May 31, 2026 and January 2, 2029. In addition, units representing 248 ordinary share equivalents were held for the officer under the STERIS Corporation 401(k) Plan as of that same date.

Positive

  • None.

Negative

  • None.
Insider McGowan Lindsey
Role VP, Chf. Comp. & Quality Offc.
Type Security Shares Price Value
Grant/Award Ordinary Shares 798 $0.00 --
holding Ordinary Shares -- -- --
Holdings After Transaction: Ordinary Shares — 5,028 shares (Direct); Ordinary Shares — 248 shares (Indirect, See Footnote Below)
Footnotes (1)
  1. As of January 2, 2026, 3,750 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 660 on May 31, 2026; 1,128 on June 2, 2026; 588 on June 4, 2027; 576 on June 3, 2028 and 798 on January 2, 2029. Units representing 248 ordinary share equivalents are held on behalf of the Reporting Person under the STERIS Corporation 401(k) Plan as of January 2, 2026.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
McGowan Lindsey
(Last) (First) (Middle)
70 SIR JOHN ROGERSON'S QUAY
(Street)
DUBLIN 2 L2 D02 R296
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
STERIS plc [ STE ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
VP, Chf. Comp. & Quality Offc.
3. Date of Earliest Transaction (Month/Day/Year)
01/02/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Ordinary Shares 01/02/2026 A 798 A $0 5,028(1) D
Ordinary Shares 248 I See Footnote Below(2)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. As of January 2, 2026, 3,750 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 660 on May 31, 2026; 1,128 on June 2, 2026; 588 on June 4, 2027; 576 on June 3, 2028 and 798 on January 2, 2029.
2. Units representing 248 ordinary share equivalents are held on behalf of the Reporting Person under the STERIS Corporation 401(k) Plan as of January 2, 2026.
Remarks:
/s/ John P. Ubbing, Authorized Representative under Power of Attorney 01/06/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did STERIS plc (STE) report in this Form 4?

The filing reports that on January 2, 2026, a STERIS officer acquired 798 ordinary shares of STERIS plc at a reported price of $0 per share, reflecting an equity grant.

Who is the insider involved in this STERIS plc (STE) Form 4 and what is their role?

The reporting person is an Officer of STERIS, serving as VP, Chief Comp. & Quality Officer, and the filing is made by one reporting person.

How many STERIS plc (STE) shares does the officer own after the reported transaction?

Following the reported transaction, the officer beneficially owned 5,028 ordinary shares directly, plus units representing 248 ordinary share equivalents held on their behalf under the STERIS Corporation 401(k) Plan as of January 2, 2026.

What portion of the STERIS plc (STE) shares are restricted and when do they vest?

As of January 2, 2026, 3,750 of the officer’s directly held ordinary shares were restricted. These restrictions lapse in installments: 660 on May 31, 2026, 1,128 on June 2, 2026, 588 on June 4, 2027, 576 on June 3, 2028, and 798 on January 2, 2029.

Does the STERIS plc (STE) Form 4 report any derivative securities transactions?

The included Table II format relates to derivative securities, but no specific derivative security acquisitions or dispositions are listed in the provided content.

How are the additional STERIS plc (STE) share equivalents held for the officer?

The filing states that units representing 248 ordinary share equivalents are held on behalf of the reporting person under the STERIS Corporation 401(k) Plan as of January 2, 2026.